Today, electroCore, Inc. revealed that the first eight participants have been enrolled in a new clinical trial carried out by Acacia Clinics in partnership with the Vagus Nerve Society. This commercial-stage bioelectronic medicine and wellness company, listed on Nasdaq as ECOR, disclosed the start of the study in Rockaway, N.J.